Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus
Xuan Liu,Lunzhi Yuan,Jijing Chen,Yali Zhang,Peiwen Chen,Ming Zhou,Jiaxuan Xie,Jian Ma,Jianzhong Zhang,Kun Wu,Qiyi Tang,Quan Yuan,Huachen Zhu,Tong Cheng,Yi Guan,Gang Liu,Ningshao Xia
DOI: https://doi.org/10.1002/advs.202207249
IF: 15.1
2023-04-27
Advanced Science
Abstract:IFN‐I‐dependent endogenous antiviral response is vital to inhibit highly pathogenic coronavirus replication and prevent ARDS. A biomimetic antiviral nanobiologic administered intranasally breaks the general mode of action of direct‐acting antivirals, triggers a swift production and signaling of IFN‐I, and reverses the imbalanced innate immune responses to defend SARS‐CoV‐2 that with high mutation rates and fairly strong immunepathogenicity. Highly pathogenic coronavirus (CoV) infection induces a defective innate antiviral immune response coupled with the dysregulated release of proinflammatory cytokines and finally results in acute respiratory distress syndrome (ARDS). A timely and appropriate triggering of innate antiviral response is crucial to inhibit viral replication and prevent ARDS. However, current medical countermeasures can rarely meet this urgent demand. Here, an antiviral nanobiologic named CoVR‐MV is developed, which is polymerized of CoVs receptors based on a biomimetic membrane vesicle system. The designed CoVR‐MV interferes with the viral infection by absorbing the viruses with maximized viral spike target interface, and mediates the clearance of the virus through its inherent interaction with macrophages. Furthermore, CoVR‐MV coupled with the virus promotes a swift production and signaling of endogenous type I interferon via deregulating 7‐dehydrocholesterol reductase (DHCR7) inhibition of interferon regulatory factor 3 (IRF3) activation in macrophages. These sequential processes re‐modulate the innate immune responses to the virus, trigger spontaneous innate antiviral defenses, and rescue infected Syrian hamsters from ARDS caused by SARS‐CoV‐2 and all tested variants.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry